Futura Medical plc (FUM.L)
GBp 32.6
(-0.15%)
GBp 32.6
(-0.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 570.25 Thousand | -5.77 Million | -3.87 Million | -4.54 Million | -6.65 Million | -4.7 Million |
| Net Income | -6.89 Million | -6.87 Million | -5.86 Million | -2.92 Million | -11.14 Million | -7.23 Million |
| Depreciation & Amortization | 130.27 Thousand | 24.73 Thousand | 19.8 Thousand | 25 Thousand | 20.7 Thousand | 19.85 Thousand |
| Deferred income taxes | 1.07 Million | - | - | 2.22 Million | 1.35 Million | 928.09 Thousand |
| Stock-based compensation | 2.72 Million | 671.85 Thousand | 181.82 Thousand | 149.36 Thousand | 101.4 Thousand | 146.83 Thousand |
| Change in working capital | 3.61 Million | -511.5 Thousand | 1.27 Million | -4.01 Million | 3.02 Million | 1.46 Million |
| Other non-cash items | -71.79 Thousand | 911.06 Thousand | 519.21 Thousand | -924.00 | -22.28 Thousand | -27.57 Thousand |
| Investing Cash Flow | -1.43 Million | -740.69 Thousand | -419.72 Thousand | -7447.00 | -10.45 Thousand | 23.06 Thousand |
| Investments in PPE | -1.5 Million | -740.69 Thousand | -419.72 Thousand | -8371.00 | -32.73 Thousand | -4510.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 71.79 Thousand | - | - | 924.00 | 22.28 Thousand | 27.57 Thousand |
| Financing Cash Flow | 4.54 Million | 169.58 Thousand | 13.64 Million | 3.05 Million | 19.28 Thousand | 5.48 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.54 Million | 169.58 Thousand | 14.31 Million | 3.27 Million | 19.28 Thousand | 5.94 Million |
| Other Financing Activities | - | - | -672.31 Thousand | -211.63 Thousand | - | -463.18 Thousand |
| Accounts receivables | -974.49 Thousand | -186.42 Thousand | -39.46 Thousand | 61.4 Thousand | 204.92 Thousand | -125.33 Thousand |
| Accounts payables | - | -325.07 Thousand | 1.31 Million | -4.08 Million | 2.82 Million | 1.52 Million |
| Inventory | -339.00 | - | - | 7780.00 | - | 62.63 Thousand |
| Other working capital | 3.61 Million | - | - | - | - | - |
| Cash at beginning of period | 4.02 Million | 10.37 Million | 1.01 Million | 2.51 Million | 9.15 Million | 8.36 Million |
| Cash at end of period | 7.71 Million | 4.02 Million | 10.37 Million | 1.01 Million | 2.51 Million | 9.15 Million |
| Capital Expenditure | -1.5 Million | -740.69 Thousand | -419.72 Thousand | -8371.00 | -32.73 Thousand | -4510.00 |
| Effect of forex changes on cash | 2001.00 | - | - | - | 1.00 | - |
| Net cash flow / Change in cash | 3.68 Million | -6.34 Million | 9.35 Million | -1.49 Million | -6.64 Million | 795.27 Thousand |
| Free Cash Flow | -935.59 Thousand | -6.51 Million | -4.29 Million | -4.55 Million | -6.68 Million | -4.71 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1 Million | -6.89 Million | -1.75 Million | -6.87 Million | -3.34 Million | -2.49 Million |
| Depreciation & Amortization | 59.41 Thousand | 130.27 Thousand | 65.28 Thousand | 24.73 Thousand | 12.36 Thousand | 12.36 Thousand |
| Deferred income taxes | - | 1.07 Million | - | - | - | - |
| Stock-based compensation | - | 2.72 Million | - | 671.85 Thousand | - | - |
| Change in working capital | -5.23 Million | 3.61 Million | -363.27 Thousand | -511.5 Thousand | 198.2 Thousand | -709.7 Thousand |
| Other non-cash items | 1.17 Million | -71.79 Thousand | 1.96 Million | 911.06 Thousand | 603.86 Thousand | 515.02 Thousand |
| Investing Cash Flow | -823.23 Thousand | -1.43 Million | -6886.00 | -740.69 Thousand | -439.07 Thousand | -301.62 Thousand |
| Investments in PPE | -823.23 Thousand | -1.5 Million | -6886.00 | -740.69 Thousand | -439.07 Thousand | -301.62 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 71.79 Thousand | - | - | - | - |
| Financing Cash Flow | 23.23 Thousand | 4.54 Million | 4.4 Million | 169.58 Thousand | 147.75 Thousand | 21.83 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 23.23 Thousand | 4.54 Million | 4.4 Million | 169.58 Thousand | 147.75 Thousand | 21.83 Thousand |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -555.46 Thousand | - | -804.68 Thousand | -186.42 Thousand | -166.07 Thousand | -20.35 Thousand |
| Accounts payables | -4.68 Million | - | 442.21 Thousand | -325.07 Thousand | 364.27 Thousand | -689.35 Thousand |
| Inventory | 200.00 | -339.00 | -809.00 | - | - | - |
| Other working capital | - | 3.61 Million | - | - | - | - |
| Cash at beginning of period | 7.71 Million | 4.02 Million | 4.02 Million | 10.37 Million | 6.67 Million | 10.37 Million |
| Cash at end of period | 3.92 Million | 7.71 Million | 7.83 Million | 4.02 Million | 4.02 Million | 6.67 Million |
| Capital Expenditure | -823.23 Thousand | -1.5 Million | -6886.00 | -740.69 Thousand | -439.07 Thousand | -301.62 Thousand |
| Effect of forex changes on cash | - | 2001.00 | - | - | - | - |
| Net cash flow / Change in cash | -3.78 Million | 3.68 Million | 3.81 Million | -6.34 Million | -2.65 Million | -3.69 Million |
| Free Cash Flow | -3.82 Million | -935.59 Thousand | -594 Thousand | -6.51 Million | -2.79 Million | -3.71 Million |
DSSL
3L7A
GWIN
0QYL
GREAVESCOT
CMRX